Recombinant vesicular stomatitis virus (Mayo Clinic)

N/A

Report date: 2022/12/26 12:27:29

Base Information

Drug NameRecombinant vesicular stomatitis virus (Mayo Clinic)
Drug Alias Name重组水泡性口炎病毒-Mayo ClinicVSV-IFNbetaTYRP1
ClassificationBiologicsNatural product/Extract > Microbial extract
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsUveal melanomaSkin MelanomaMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesMayo Clinic
China Registration ClassN/A

Develop Information

Active CompaniesMayo Clinic
Inactive CompaniesN/A
Active IndicationsUveal melanomaMelanoma
Inactive IndicationsSkin Melanoma

Other Information

ATC CodeN/A
Related LinksN/A